3,189 results on '"Nguyen, Paul"'
Search Results
202. Association of tympanostomy tubes with future assistive hearing devices–a population based study
203. Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer Care
204. A population-based study of the treatment effect of first-line ipilimumab for metastatic or unresectable melanoma
205. An Update to Changing Patterns of Anal Carcinoma in the United States
206. Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes
207. Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer
208. The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness
209. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
210. Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training
211. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
212. Supplementary Figure Legend from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer
213. Supplementary Figure Legends from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model
214. Supplemental Figure 2. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
215. Data from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
216. Supplementary Table 2 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
217. Supplementary Table 4 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
218. Supplemental Figure 5. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
219. Supplementary materials from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
220. Supplementary Table 1 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
221. Supplementary Figures 1 through 7 and Supplementary Table 1 from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model
222. Supplementary tables from Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
223. Data from Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism
224. Supplementary Table 3 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
225. Supplementary Figures from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas
226. Supplementary Table 1 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer
227. Supplementary Methods from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model
228. Supplementary Figure 1 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer
229. Supplemental Figure 4. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
230. Supplementary figures from Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
231. supp Tables from Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
232. Supplementary Figure 2 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer
233. Supplemental Figure 1. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
234. Supplementary Data from Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism
235. Sup Fig 1 from Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
236. Supplemental Figure 3. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
237. Sup Fig 2 from Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy
238. Data from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model
239. Comparison of Two Culture-Based Detection Systems for the Isolation of Arcobacter butzleri, Arcobacter cryaerophilus, and Arcobacter skirrowii in Raw Ground Poultry
240. FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP).
241. Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study
242. Uncontrolled Cardiovascular Risk Factors in Prostate Cancer Patients
243. Mapping of Primary Care and Health Care Utilization in Naturally Occurring Retirement Communities: Ontario, Canada
244. Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center
245. Recent relocation and decreased survival following a cancer diagnosis
246. The influence of marital status on the use of breast, cervical, and colorectal cancer screening
247. Quantification of the External Validity of Randomized Controlled Trials Supporting Clinical Care Guidelines: The Case of Thromboprophylaxis
248. ACR Appropriateness Criteria Renal Cell Carcinoma Staging
249. The impact of Medicare eligibility on cancer screening behaviors
250. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.